Cytimmune Sciences
Rockville, US
Biotech
Founders & leadership
MW
Marc W. StanleyDirector
NW
Norman W. ZoberDirector
MS
Mitchell S. MarderExecutive Officer
LT
Lawrence TamarkinExecutive Officer, Director
JW
John W. HoladayDirector
HK
Hidetaka Kentaro ItaniDirector
RW
Robert W. AshtonDirector
GF
Giulio F. PaciottiExecutive Officer
NW
Neal W. CohenDirector
GF
Gary F. RosenfeldExecutive Officer
Reported raises · per SEC filings
Form D private placements$997.8KraisedDec 2020 · 1 investors · Biotechnology
Rule 506(b)$50KraisedApr 2020 · 1 investors · Biotechnology
Rule 506(b)$75KraisedMar 2019 · 2 investors · Biotechnology
Rule 506(b)$30KraisedOct 2017 · 2 investors · Biotechnology
Rule 506(b)$100.8KraisedJan 2017 · 3 investors · Biotechnology
Rule 506(b)$747.7KraisedAug 2015 · 1 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.